By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Eli Lilly and Company 

Lilly Corporate Center

Indianapolis  Indiana  46285  U.S.A.
Phone: 317-276-2000 Fax: n/a

Lilly makes medicines that help people live longer, healthier, more active lives. We were founded by Eli Lilly in 1876, and are now the 10th largest pharmaceutical company in the world. We have steadfastly remained independent, but not isolated. Across the globe, Lilly has developed productive alliances and partnerships that advance our capacity to develop innovative medicines at lower costs. Lilly is consistently ranked as one of the best companies in the world to work for, and generations of Lilly employees have sustained a culture that values excellence, integrity, and respect for people. Lilly's global employees number approximately 40,000, and our medicines are marketed in 143 countries. Lilly has major research and development facilities in eight countries and conducts clinical trials in more than 50 countries.

Making medicines has never been easy. But in today's global health care environment, the challenges are unprecedented. Familiar ways of working aren't working anymore, so Lilly is transforming to meet the challenges head on — from how we make medicines to how we talk about them. Throughout our organization, we're asking tough questions and discovering better answers.

Around the world people are in need of health care. People with medical needs above and beyond the capabilities of existing medicine. It is here, at the edge of science and medicine that Lilly begins. Lilly has embraced a bold vision. We intend to make a significant contribution to humanity by improving global health in the 21st century. Starting with the work of our scientists, we will place improved outcomes for individual patients at the center of what we do. We will listen carefully to understand patient needs and work with health care partners to provide meaningful benefits for the people who depend on us.

Lilly, a leading innovation driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers through medicines and information for some of the world’s most urgent medical needs.

Key Statistics

Ownership: Public

Web Site: Eli Lilly
Employees: 41,500 globally
Symbol: LLY



SLIL Biomedical Corporation  Worldwide licensing agreement with the animal health division for more than 40 compounds that have shown activity in animal infectious diseases.

Emisphere Technologies, Inc.  Osteoporosis; Growth disorders

PanVera LLC 

Medarex, Inc. 

MacroGenics, Inc. 

Daiichi Sankyo, Inc. 

Dyax Corp.  Antibody phage display

Company News
Eli Lilly (LLY) Stock Falls 10 Percent After Company Halts Late-Stage Cholesterol Drug 10/12/2015 6:29:24 AM
Eli Lilly (LLY) Acquires Phase III Intranasal Glucagon From Locemia Solutions 10/12/2015 6:10:44 AM
Eli Lilly (LLY), China-based Innovent Biologics Expand Cancer Drug Collaboration With $1 Billion PD-1 Pact 10/12/2015 6:06:48 AM
Eli Lilly (LLY) Expands Third Tech Facility this Year, Adding Another 50 Jobs in New York 10/9/2015 5:52:32 AM
Eli Lilly (LLY) Confirms Date And Conference Call For Third-Quarter 2015 Financial Results Announcement 10/8/2015 7:28:58 AM
Eli Lilly (LLY) Gains FDA Breakthrough Therapy Designation for Abemaciclib 10/8/2015 5:48:33 AM
Eli Lilly (LLY) Joins The Imaging Dementia - Evidence For Amyloid Scanning (IDEAS) Study 10/7/2015 6:58:35 AM
Eli Lilly (LLY) To Showcase Data For Investigational Psoriasis Treatment At 24th European Academy Of Dermatology And Venereology Congress 10/6/2015 10:01:40 AM
Adocia And Eli Lilly (LLY) Initiate A Phase 1b Study Evaluating Ultra-Rapid Biochaperone Lispro In Patients With Type 1 Diabetes Using Insulin Pump Therapy 10/6/2015 9:32:02 AM
Zosano (ZSAN) Terminates Eli Lilly (LLY) Deal, Halts Daily Osteoporosis Drug Program 9/29/2015 6:11:26 AM